Literature DB >> 16132726

Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages.

Thomas Westendorf1, Juergen Graessler, Steffi Kopprasch.   

Abstract

The uptake of oxidized low-density lipoprotein (oxLDL) by scavenger receptors of macrophages with resulting foam cell formation is considered a critical event in atherogenesis. Since hypochlorite-oxidized LDL (HOCl-LDL) has been shown to be recognized by macrophages and evidence was provided that HOCl-LDL is internalized via class B scavenger receptors CD36 and SR-BI, the regulatory relationships between CD36, SR-BI, and the nuclear transcription factor PPARgamma in murine macrophages (RAW 264.7) on exposure to HOCl-LDL were examined. Using the highly sensitive real-time RT-PCR we could demonstrate that HOCl-LDL upregulated CD36 and PPARgamma levels dose- and time dependently while modulating SR-BI message levels differently in dependence on HOCl-LDL concentration and incubation time. On exposure of macrophages to HOCl-LDL but not native LDL in varying concentrations, a significant positive correlation between CD36 and PPARgamma (rho = 0.603, p = 0.001) was observed indicating the presence of a positive feedback mechanism by which HOCl-LDL could promote its own uptake. The transcriptional expression of SR-BI in macrophages was not significantly related to PPARgamma mRNA levels after treatment with HOCl-LDL suggesting a differential regulation of the two members of the scavenger receptor class B family in response to HOCl-LDL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132726     DOI: 10.1007/s11010-005-5873-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes.

Authors:  Lene Malerød; Lene K Juvet; Audun Hanssen-Bauer; Winnie Eskild; Trond Berg
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

2.  Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I.

Authors:  J Han; A C Nicholson; X Zhou; J Feng; A M Gotto; D P Hajjar
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

3.  The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells.

Authors:  Steffi Kopprasch; Jens Pietzsch; Thomas Westendorf; Hans-Joachim Kruse; Jürgen Grässler
Journal:  Int J Biochem Cell Biol       Date:  2004-03       Impact factor: 5.085

4.  Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages.

Authors:  Ian C Kavanagh; Carole E Symes; Pauline Renaudin; Esther Nova; Maria Dolores Mesa; George Boukouvalas; David S Leake; Parveen Yaqoob
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

5.  CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.

Authors:  G Chinetti; F G Gbaguidi; S Griglio; Z Mallat; M Antonucci; P Poulain; J Chapman; J C Fruchart; A Tedgui; J Najib-Fruchart; B Staels
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

6.  Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma.

Authors:  L Nagy; P Tontonoz; J G Alvarez; H Chen; R M Evans
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

7.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

Authors:  S L Hazen; J W Heinecke
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

8.  Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells.

Authors:  S Kopprasch; W Leonhardt; J Pietzsch; H Kühne
Journal:  Atherosclerosis       Date:  1998-02       Impact factor: 5.162

9.  Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.

Authors:  E Malle; G Waeg; R Schreiber; E F Gröne; W Sattler; H J Gröne
Journal:  Eur J Biochem       Date:  2000-07

Review 10.  Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.

Authors:  J Plutzky
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

View more
  9 in total

1.  Influence of oxidatively modified LDL on monocyte-macrophage differentiation.

Authors:  Achuthan Radhika; Shiney S Jacob; Perumana R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2007-07-28       Impact factor: 3.396

2.  Upregulation of macrophage-specific functions by oxidized LDL: lysosomal degradation-dependent and -independent pathways.

Authors:  A Radhika; P R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2012-09-30       Impact factor: 3.396

3.  Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages.

Authors:  J Graessler; J Pietzsch; T Westendorf; U Julius; S R Bornstein; S Kopprasch
Journal:  Diabetologia       Date:  2007-03-23       Impact factor: 10.122

Review 4.  Role of myeloperoxidase in inflammation and atherosclerosis (Review).

Authors:  Christian Frangie; Jalil Daher
Journal:  Biomed Rep       Date:  2022-05-06

5.  Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.

Authors:  P J Simpson-Haidaris; S J Pollock; S Ramon; N Guo; C F Woeller; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2010-02-28       Impact factor: 4.964

6.  High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells.

Authors:  Qichun Zhang; Yun Zhang; Haihua Feng; Rui Guo; Lai Jin; Rong Wan; Lina Wang; Cheng Chen; Shengnan Li
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

7.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Authors:  Zeneng Wang; Elizabeth Klipfell; Brian J Bennett; Robert Koeth; Bruce S Levison; Brandon Dugar; Ariel E Feldstein; Earl B Britt; Xiaoming Fu; Yoon-Mi Chung; Yuping Wu; Phil Schauer; Jonathan D Smith; Hooman Allayee; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Nature       Date:  2011-04-07       Impact factor: 49.962

Review 8.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

9.  Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation.

Authors:  Kousei Ohshima; Masaki Mogi; Masatsugu Horiuchi
Journal:  Int J Vasc Med       Date:  2012-07-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.